TY - JOUR
T1 - Pro
T2 - “Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?”
AU - Li, Yan
AU - Adusumilli, Prasad S.
AU - Chou, Teh Ying
AU - Kadota, Kyuichi
AU - Mino-Kenudson, Mari
AU - Papotti, Mauro
AU - Rekhtman, Natasha
AU - Yagi, Yukako
AU - Yatabe, Yasushi
AU - Travis, William D.
N1 - Publisher Copyright:
© 2024 International Association for the Study of Lung Cancer
PY - 2024/5
Y1 - 2024/5
N2 - In this PRO-CON debate, you will read very different perspectives about a simple question regarding an observation under the microscope: What is the significance of tumor cells in the air spaces of the lung parenchyma beyond the tumor edge of a resected lung cancer? An important underlying question is whether this entire PRO-CON debate is a mere academic exercise or whether spread through air spaces (STAS), as currently defined, describes a clinically useful phenomenon. The journey of STAS began with a complete paradigm shift to reverse the thinking that all air space tumor cells beyond the edge of lung cancers are an artifact. This led to a new concept where STAS could be separated from artifacts with a definition that has proven to be clinically useful. As with any major change in thinking, it is understandable that there would be some disagreement with this paradigm shift. Nevertheless, after a decade since it was described, many pathologists and clinicians around the world have found STAS to provide important information about the behavior of lung cancer. Numerous PRO-STAS articles supporting the usefulness of STAS have been published with clinical data on many thousands of patients from numerous institutions all over the world. In contrast, for the CON-STAS articles, widespread international representation and data are limited. It is now difficult to ignore the numerous reports and is reasonable to consider how to use the presence of STAS in clinical decisions. Hopefully, this PRO-CON debate will further stimulate clinical and scientific investigations aimed at a better understanding of STAS.
AB - In this PRO-CON debate, you will read very different perspectives about a simple question regarding an observation under the microscope: What is the significance of tumor cells in the air spaces of the lung parenchyma beyond the tumor edge of a resected lung cancer? An important underlying question is whether this entire PRO-CON debate is a mere academic exercise or whether spread through air spaces (STAS), as currently defined, describes a clinically useful phenomenon. The journey of STAS began with a complete paradigm shift to reverse the thinking that all air space tumor cells beyond the edge of lung cancers are an artifact. This led to a new concept where STAS could be separated from artifacts with a definition that has proven to be clinically useful. As with any major change in thinking, it is understandable that there would be some disagreement with this paradigm shift. Nevertheless, after a decade since it was described, many pathologists and clinicians around the world have found STAS to provide important information about the behavior of lung cancer. Numerous PRO-STAS articles supporting the usefulness of STAS have been published with clinical data on many thousands of patients from numerous institutions all over the world. In contrast, for the CON-STAS articles, widespread international representation and data are limited. It is now difficult to ignore the numerous reports and is reasonable to consider how to use the presence of STAS in clinical decisions. Hopefully, this PRO-CON debate will further stimulate clinical and scientific investigations aimed at a better understanding of STAS.
KW - Lung cancer
KW - Prognosis
KW - Spread through air spaces
KW - Stage
KW - STAS
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=85190544833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85190544833&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2024.03.001
DO - 10.1016/j.jtho.2024.03.001
M3 - Editorial
AN - SCOPUS:85190544833
SN - 1556-0864
VL - 19
SP - 677
EP - 697
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 5
ER -